Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
Marie Sébert, Lucie Freiman,Cendrine Chaffaut,Agnès Guerci,Pierre Peterlin,Sylvain Thépot,Odile Beyne-Rauzy,Sophie Park,Thomas Cluzeau,Fatiha Chermat,Pierre Fenaux,Claude Preudhomme,Emmanuelle Clappier,Sylvie Chevret,Lionel Adès,Nicolas Duployez,Matthieu Duchmann Leukemia（2024）
AI 理解论文
溯源树
样例
